Diana Saleiro

8PUBLICATIONS
54CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursInnate immunityTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 21, 2025
Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies.

Elspeth M Beauchamp, Atul Jain, Matt Clutter

|Oct 28, 2025
Schlafen 12 Modulation and Targeting in Acute Myeloid Leukemia.

Jamie N Guillen Magaña, Markella Zannikou, Aneta Baran

|Jul 23, 2025
Loss of Function Mouse Models Reveal a Novel Regulatory Function for ULK1 in Myeloproliferative Neoplasms.

Diana Saleiro, Jeremy Q Wen, Markella Zannikou

|Jun 28, 2023
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells.

Diana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti

|Dec 27, 2022
Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors.

Sarah E Fenton, Markella Zannikou, Liliana Ilut

|Apr 03, 2021
Type I and II Interferons in the Anti-Tumor Immune Response.

Sarah E Fenton, Diana Saleiro, Leonidas C Platanias

Pageof 2